• 1. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

Recent Advances in the Study of 2-(4-methylpiperidin-1-yl)pyridin-3-amine (CAS: 926205-46-1)

2-(4-methylpiperidin-1-yl)pyridin-3-amine (CAS: 926205-46-1) is a chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. Recent studies have focused on elucidating its pharmacological properties, synthetic pathways, and mechanisms of action, particularly in the context of drug discovery and development. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its significance in current scientific endeavors.

The compound, characterized by its pyridine and piperidine moieties, has been investigated for its role as a building block in the synthesis of more complex molecules. Researchers have explored its utility in the development of kinase inhibitors, which are crucial for targeting various signaling pathways implicated in diseases such as cancer and inflammatory disorders. The structural flexibility of 2-(4-methylpiperidin-1-yl)pyridin-3-amine allows for modifications that can enhance its binding affinity and selectivity towards specific biological targets.

Recent publications have detailed innovative synthetic routes to produce 2-(4-methylpiperidin-1-yl)pyridin-3-amine with high yield and purity. These methods often involve multi-step reactions, including amination and cyclization processes, which are optimized to minimize by-products and improve scalability. Advances in catalytic systems and green chemistry principles have further refined these synthetic approaches, making them more efficient and environmentally friendly.

In vitro and in vivo studies have demonstrated the compound's potential as a modulator of key enzymatic activities. For instance, it has shown promising results in inhibiting specific kinases involved in cell proliferation and survival. These findings are supported by detailed structural-activity relationship (SAR) analyses, which provide insights into how modifications to the compound's core structure can influence its biological activity. Such studies are instrumental in guiding the design of next-generation therapeutics.

Despite these advancements, challenges remain in translating the preclinical findings into clinical applications. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed through further research. Collaborative efforts between academic institutions and pharmaceutical companies are essential to overcome these hurdles and accelerate the development of 2-(4-methylpiperidin-1-yl)pyridin-3-amine-based drugs.

In conclusion, 2-(4-methylpiperidin-1-yl)pyridin-3-amine represents a promising scaffold in medicinal chemistry, with ongoing research uncovering its diverse applications. The compound's versatility and the continuous refinement of its synthetic and pharmacological profiles underscore its potential to contribute significantly to the development of novel therapeutics. Future studies should focus on optimizing its properties and exploring its efficacy in more complex biological systems.

• 55403-29-7(6-piperidin-1-ylpyridin-3-amine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)